LabCorp Launches New Enhanced Report for Medical Drug Monitoring

BURLINGTON, N.C.--(BUSINESS WIRE)--Nov. 30, 2015-- Laboratory Corporation of America^® Holdings (LabCorp^®) (NYSE:LH) announced today that MedTox Laboratories (MedTox), a member of the LabCorp Specialty Testing Group, introduced a new enhanced report for medical drug monitoring, the LabCorp MedWatch^® ToxAssure^® report. The ToxAssure report provides a visual summary of test result findings and is designed to assist physicians in monitoring drug test results relative to a patient’s prescribed medications.



Laboratory Corporation of America - Investor Relations - RSS Content